Luminex Says Q2 Revenue Grew 20 Percent as Loss Swings to Profit | GenomeWeb
NEW YORK (GenomeWeb News) – Luminex today said total second-quarter revenues increased 25 percent as a net loss turned into a profit.
 
Receipts for the three months ended June 30 increased to $13 million from $10.7 million year over year. The company said it generated $5.8 million from the sale of 205 Luminex Systems in the period.
 
R&D costs increased 20 percent to $1.8 million from $1.5 million from the comparable quarter a year ago.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.